Tuesday, January 30, 2007

Kefir – a complex probiotic

......................................................................................................................................................................
Kefir – a complex probiotic
Edward R. Farnworth
Food Research and Development Centre, Agriculture and Agri-food Canada, St. Hyacinthe, Quebec, Canada J2S 8E3.
Tel. 450-773-1105. Fax 450-8461. E-mail farnworthed@agr.gc.ca
Abstract
Kefir is a fermented milk drink produced by the actions of bacteria and yeasts contained in kefir grains, and
is reported to have a unique taste and unique properties. During fermentation, peptides and exopolysacchar-
ides are formed that have been shown to have bioactive properties. Moreover, in vitro and animal trials have
shown kefir and its constituents to have anticarcinogenic, antimutagenic, antiviral and antifungal properties.
Although kefir has been produced and consumed in Eastern Europe for a long period of time, few clinical
trials are found in the scientific literature to support the health claims attributed to kefir. The large number of
microorganisms in kefir, the variety of possible bioactive compounds that could be formed during fermenta-
tion, and the long list of reputed benefits of eating kefir make this fermented dairy product a complex
probiotic.
Keywords: kefir, probiotics, kefir grains, kefiran, human health, bioactive ingredients
known than yoghurt; however, an analysis of its composi-
1. Introduction
tion indicates that it may contain bioactive ingredients that
Archaeological evidence has indicated that the process of give it unique health benefits, which means that kefir may
fermentation in foods was discovered accidentally thou- be an important probiotic product (Farnworth 1999).
sands of years ago. However, over time, it soon became
apparent that many fermented foods had longer storage
2. Origins of kefir
lives and improved nutritional values compared to their
Kefir is a viscous, slightly carbonated dairy beverage that
unfermented equivalents, making this form of food proces-
contains small quantities of alcohol and, like yoghurt, is
sing a popular technique. It is not surprising, therefore, to
believed to have its origins in the Caucasian mountains of
find that many foods including vegetables, fruits, cereals,
the former USSR. It is also manufactured under a variety
meat and fish have all been converted into desirable food
of names including kephir, kiaphur, kefer, knapon, kepi
products by fermentation and are still being consumed
and kippi (Koroleva 1988a), with artisanal production of
throughout the world today (Farnworth 2004).
kefir occurring in countries as widespread as Argentina,
Certain bacteria, either alone or through the changes
Taiwan, Portugal, Turkey and France (Thompson et al.
they bring about during fermentation, have been shown to
1990; Angulo et al. 1993; Lin et al. 1999; Garrote et al.
have positive effects on health as well as resistance to dis-
2001; Santos et al. 2003; Gulmez and Guven 2003). It is
ease. Interest in such probiotic species has increased in
not clear whether all kefirs originate from a single original
recent years as more is learned about the microorganisms
starter culture, since microbial analyses of kefir samples
used in the fermentation process, and the possibility of
taken from different locations indicate microflora popula-
adding beneficial bacteria to food products. Furthermore,
tion differences.
consumers are increasingly looking to improve their health
The FAO/WHO (2001) have proposed a definition of
and increase their resistance to disease through dietary
kefir based on the microbial composition of both kefir
means.
grains (the starter culture used to produce kefir) and the
Fermented dairy products from milk from a variety of
final kefir product (see Table 1).
animals are perhaps the most common fermented foods
worldwide. Yoghurt, which is known by many different
names in different countries, is a fermented product which 3. Kefir manufacture
is familiar to consumers. Kefir, meanwhile, is less well
Although commercial kefir is traditionally manufactured
from cows’ milk, it has also been made from the milk of
Food Science and Technology Bulletin: Functional Foods 2 (1) 1–17
ewes, goats and buffalos. Moreover, kefir produced using
DOI: 10.1616/1476-2137.13938. Published 4 April 2005
ISSN 1476-2137 # IFIS Publishing 2005. All Rights Reserved soy milk has also been recently reported (Ismail et al.
Kefir – a complex probiotic E.R. Farnworth
2
lactic acid production and ethanol production, compared
Table 1. Codex Alimentarius description of kefir*
to kefir produced from soy milk alone (Liu and Lin 2000).
Definition
The grains used in this study were found to have a-galac-
Starter culture prepared from kefir grains, Lactobacillus kefiri, tosidase activity that helped explain how these kefir grains
and species of the genera Leuconostoc, Lactococcus and
were able to use the galactose-based carbohydrates which
Acetobacter growing in a strong specific relationship. Kefir
occur in soy milk.
grains constitute both lactose-fermenting yeasts (Kluyveromyces
Kefir grains are key to kefir production, and it has been
marxianus) and non-lactose-fermenting yeasts (Saccharomyces
unisporus, Saccharomyces cerevisiae and Saccharomyces found that the finished product has a different microbiolo-
exiguus). gical profile from the grains and therefore cannot be used
to inoculate a new batch of milk (Simova et al. 2002).
Composition
Grains have been shown to possess a dynamic and com-
Milk protein (% w/w) min. 2.8
plex flora which is not conducive to commercial produc-
<10
Milk fat (% m/m)
tion of a uniform, stable product; this has prompted
Titratable acidity, expressed as % of lactic acid min. 0.6
groups to try to produce kefir from a mixture of pure cul-
(% m/m)
tures (Petersson et al. 1985). Duitschaever et al. (1987,
Ethanol (% vol./w) not stated
1988a) combined a yoghurt culture with three other lactic
min. 107
Sum of specific microorganisms constituting the
acid bacteria and Saccharomyces cerevisiae (a non-lactose
starter culture (cfu/g, in total)
fermenting yeast) to produce a fermented milk with kefir
min. 104
Yeasts (cfu /g)
characteristics (which produced CO2 and contained etha-
*From Codex Standard for Fermented Milks CODEX STAN 243-2003
nol) under a variety of conditions. Rossi and Gobbetti
(1991) produced a multistarter culture using four bacteria
and two yeasts isolated from kefir grains in order to manu-
´
1983; Mann 1985; Zourari and Anifantakis 1988; Halle facture kefir under a continuous process. More recently,
et al. 1994; Kuo and Lin 1999). Traditionally, kefir is pro- Beshkova et al. (2002) produced a starter consisting of
duced by adding kefir grains (a mass of proteins, polysac- two bacteria (Lactobacillus helveticus and Lactococcus
charides, mesophilic, homofermentative and hetero- lactis subsp. lactis,) and one yeast (S. cerevisiae) isolated
fermentative lactic acid streptococci, thermophilic and from kefir grains and combined with two yoghurt strains
mesophilic lactobacilli, acetic acid bacteria, and yeast) to (Lactobacillus delbrueckii subsp. bulgaricus, and Strepto-
´
a quantity of milk (Koroleva 1982; Halle et al. 1994; coccus thermophilus). Yeast was added to the starter with
Tamime et al. 1999). The size of the initial kefir grain sucrose either at the beginning, or after lactic acid fermen-
inoculum affects the pH, viscosity and microbiological tation. The two resulting kefirs produced were found to
profile of the final product (Koroleva and Bavina 1970; have high numbers of viable cocci and lactobacilli and
Garrote et al. 1998). Koroleva (1991) reported that grain had chemical and organoleptic properties that were similar
to milk ratios of 1:30 to 1:50 were optimum. In some to traditional kefir. A commercial kefir is being produced
manufacturing procedures, a perculate of the grains from a in the United States using a mixture of defined microor-
coarse sieve is used as the mother culture to inoculate ganisms rather than kefir grains. This starter culture mix-
fresh milk. Fermentation of the milk by the inoculum pro- ture has been reported to contain Streptococcus lactis, L.
ceeds for approximately 24 hours, during which time plantarum, Streptococcus cremoris, L. casei, Streptococcus
homofermentative lactic acid streptococci grow rapidly, diacetylactis, Leuconostoc cremoris and Saccharomyces
initially causing a drop in pH. This low pH favours the florentinus (Hertzler and Clancy 2003).
growth of lactobacilli, but causes the streptococci numbers Starter cultures containing freeze-dried lactic acid bac-
to decline. The presence of yeasts in the mixture, together teria and yeasts from kefir grains are now available com-
with fermentation temperature (21–238C), encourages the mercially; some are supplemented with additional microor-
growth of aroma-producing heterofermentative strepto- ganisms to impart desirable characteristics in the finished
cocci. As fermentation proceeds, growth of lactic acid kefir product (Piotr Kolakowski, private communication).
bacteria is favoured over growth of yeasts and acetic acid It is evident that the final product, as produced from kefir
bacteria (Koroleva 1982). grains, will have a larger number and variety of microor-
Taiwanese researchers have shown that the lactic acid ganisms than kefir produced from a mixture of a small
bacteria from kefir grains grow more slowly in soy milk number of pure cultures.
compared to cows’ milk (Liu and Lin 2000). This may be Kefir is still most familiar to consumers in Eastern Eur-
due, in part, to the slower production of growth factors at ope, although commercial production now occurs in North
the beginning of fermentation when soy milk is the America. However, several patents can be found relating
substrate rather than cows’ milk. Addition of carbohydrate to commercial kefir production worldwide (Klupsch 1984;
(e.g. 1% glucose) to soy milk increases yeast numbers, Dmitrovskaya 1986; Tokumaru et al. 1987; Kabore 1992).
Kefir – a complex probiotic E.R. Farnworth 3
Production/consumption figures for kefir are not readily acceptability of kefir, compared to traditionally made kefir
(Duitschaever et al. 1991; Muir et al. 1999).
available since statistics for fermented dairy products are
not always broken down into separate items such as Acetaldehyde and acetoin have received particular
yoghurt and kefir (Mann 1989; Libudzisz and Piatkiewicz attention with regard to their roles during kefir manufac-
1990; Serova 1997; Zimovetz and Boyko 2000). A survey ture because of their contribution to taste; both have been
of kefir products purchased on the retail market in War- found to increase in concentration during kefir fermenta-
saw, Poland showed that 73% of products contained 107– tion. During storage, acetaldehyde increases in concentra-
109 cfu bacteria/g, and that 97% of samples were coli- ¨
tion and acetoin decreases (Guzel-Seydim et al. 2000a,
˘
¨
form-free (Molska et al. 2003). However, 48% of samples 2000b). Yuksekgag et al. (2004a), in their study of 21 iso-
did not meet FAO/WHO requirements for yeast numbers lates of lactic acid bacteria from various sources of Turk-
(FAO/WHO 2001). ish kefir, were able to show that all 21 isolates produced
acetaldehyde (0.88–4.40 mg/ml) when added to milk.
A whey beverage with an acceptable flavour has
4. Characteristics of kefir
recently been developed using kefir yeasts (Athanasiadis
et al. 2004), especially when fructose was added to fresh
The flavour, viscosity and microbial/chemical composition
milk before fermentation, and final pH of the beverage
of the final kefir product can be affected by the size of the
inoculum added to the milk, the occurrence of any agita- was 4.1. Fructose was found to increase production of sev-
tion during fermentation, and the rate, temperature and eral flavour volatiles, but did not increase fermentation
time.
duration of the cooling and ripening stages following fer-
mentation (Koroleva 1988b). Natural kefir has a refresh-
ing, yeasty taste and a ‘sparkling’ mouth feel (Kemp
5. Kefir grains
1984).
Kefir grains resemble small cauliflower florets: they mea-
Modern manufacturing procedures for kefir result in
sure 1–3 cm in length, are lobed, irregularly shaped, white
ethanol levels in the finished product of 0.01–0.1% (Koro-
to yellow-white in colour, and have a slimy but firm tex-
leva 1982), although kefir with ethanol concentrations as
`
ture (La Riviere et al. 1967; Kosikowski and Mistry 1997;
high as 0.25% have been produced from grains in the
laboratory (Kuo and Lin 1999; Simova et al. 2002; Besh- see Figure 1). Grains are kept viable by transferring them
kova et al. 2002). The amounts of ethanol and CO2 pro- daily into fresh milk and allowing them to grow for
duced during fermentation of kefir depend on the produc- approximately 20 hours; during this time, the grains will
´
have increased their mass by 25% (Halle et al. 1994).
tion conditions used. CO2 content of kefir has been said to
be ‘comparatively low’ in relation to other fermented Grains must be replicated in this way to retain their viabi-
drinks (Koroleva 1982); values of 0.85–1.05 g/l have been lity, since old and dried kefir grains have little or no abil-
`
ity to replicate (La Riviere et al. 1967). Kefir grains repli-
reported for kefir produced from kefir grains (Beshkova
et al. 2002; Simova et al. 2002) and 1.7 g/l for kefir pro-
duced from purified cultures (Gobbetti et al. 1990) How-
ever, the generation of CO2 during kefir manufacture,
especially after packaging, presents some practical pro-
blems, since the microorganisms (particularly yeasts) in
the kefir continue to grow following packaging. The con-
tainer used to package kefir must therefore be either strong
enough to withstand any pressure build up (e.g. glass) or
flexible enough to contain the volume of gas produced
(e.g. plastic with an aluminium foil top (Kwak et al.
1996).
The distinctive taste of kefir results from the presence
of several flavour compounds which are produced during
fermentation (Beshkova et al. 2003). Kefir produced from
pure cultures did not receive high sensory evaluation
scores in Canada unless it was sweetened (Duitschaever
et al. 1987, 1991); Duitschaever et al. (1987) also showed
that only about 40% of people tasting natural kefir for the
first time gave it a positive taste rating. Addition of peach Figure 1. Kefir grains. Reproduced with permission from
flavour, or modification of the fermentation process (e.g. Handbook of Fermented Functional Foods, Farnworth,
E.R. editor. Copyright CRC Press.
addition of lactococci, lactobacilli or yeasts) increased the
Kefir – a complex probiotic E.R. Farnworth
4
Table 2. Microorganisms* in kefir grains, mother
culture and kefir drink
Lactococci Lactobacilli Yeasts
Kefir grains 7.37 8.94 8.30
Mother culture 8.43 7.65 5.58
(wash of grains)
Kefir drink 8.54 7.45 5.24
*log CFU/g
1967; Koroleva et al. 1978). Analysis has shown that the
microbial profiles of the grains themselves, a percolate
taken from the grains (mother culture), and the final pro-
duct are not the same (see Table 2). This, in part, explains
why production of kefir must start with kefir grains, since
Figure 2. Electron micrograph of a kefir grain.
the final drink does not have the number or complexity of
microorganisms as the grains, preventing the drink from
cated in milk ‘at home with daily changes of milk’ and
being used as a starter culture for a new batch of kefir.
stored for three months either at room temperature or at
Kandler and Kunath (1983) reported similar results when
48C had microbiological profiles that were different to
they compared the microflora of kefir, inoculated milk
those of fresh grains (Pintado et al. 1996). In addition,
before incubation, and a mixture of kefir grains.
washing grains in water also reduced viability. It has been
recommended that in a commercial operation using grains
to produce kefir, grains should be kept viable through
6. Microbiology of kefir grains
daily transfers and should only be replaced if their ability
to ferment milk becomes impaired. (Koroleva 1982). Low
6.1 Bacteria
temperature storage appears to be the best way to maintain
kefir grains for long periods. Garrote et al. (1997) showed The microbial population found in kefir grains has been
that storage of kefir grains at À80 or À208C for 120 days used as an example of a symbiotic community (Margulis
did not change their fermentation properties compared to 1995); this symbiotic nature has made identification and
grains that had not been stored; however, grains stored at study of the constituent microorganisms within kefir grains
À48C did not produce acceptable kefir after thawing. Kefir difficult. Koroleva (1991) stated that kefir bacteria and
grains replicated in soy milk have been reported to be yeasts, when separated as pure cultures, either do not grow
smaller in size compared to grains replicated in cows’ in milk or have a decreased biochemical activity, which
milk (Liu et al. 2002). There have been no reports of suc- further complicates the study of the microbial population
cessful production of kefir grains from pure cultures. of kefir grains. Several media have been proposed for the
While early studies of kefir grains employed light isolation and identification of bacteria in kefir grains
microscopy, later investigations used electron microscopy (Kojima et al. 1993). Linossier and Dousset (1994)
to describe the complex microbial community of which showed that Lactobacillus kefir grew better when the yeast
they were comprised (Ottogalli et al. 1973; Bottazzi and Candida kefir was added to the milk. Garrote et al. (2004)
Bianchi 1980; Molska et al. 1980; Marshall et al. 1984; reported a similar observation when they attempted to
Duitschaever et al. 1988b; Toba et al. 1990; Neve 1992; grow L. kefir in milk. In general, lactic acid bacteria are
more numerous (108–109) than yeasts (105–106) and acetic
Bottazzi et al. 1994; Rea et al. 1996). Figure 2 shows an
acid bacteria (105–106) in kefir grains, although fermenta-
electron micrograph of kefir grains obtained from the
Moscow Dairy Institute. Ottogalli et al. (1973) showed tion conditions can affect this pattern (Koroleva 1991;
that the chemical and microbiological compositions of Garrote et al. 2001) Table 3 shows a list of the various
kefir grains from four different sources were different, bacteria that have been reported in kefir and kefir grains
making comparisons between results published by differ- from around the world.
ent laboratories difficult. Garrote et al. (2004) carried out several in vitro tests to
The microbial population that makes up kefir grains try to explain how the bacteria in kefir grains function.
appears to be relatively constant over time, although sea- They showed that two of the heterofermentative lactoba-
sonal variations in the grain flora have been noted which cilli, L. kefir and L. parakefir, possessed S-layer proteins
`
can affect the final product consistency (La Riviere et al. that can be used to explain in part their auto-aggregation
Kefir – a complex probiotic E.R. Farnworth 5
the yeasts in kefir grains provide an environment for the
Table 3. Bacteria found in kefir grains and kefir
growth of kefir bacteria, producing metabolites that contri-
Lactobacilli bute to the flavour and mouthfeel of kefir (Clementi et al.
kefir a,c,j,n,o,p,r Lactobacillus delbrueckii a,h,p
Lactobacillus
1989; Kwak et al. 1996; Simova et al. 2002). Table 4 lists
kefiranofaciens l,n,p Lactobacillus rhamnosus a,r
Lactobacillus
the various yeasts that have been reported in kefir grains.
kefirgranum n Lactobacillus casei h
Lactobacillus
To prevent excessive CO2 production (particularly after
parakefir n,o Lactobacilli paracasei p
Lactobacillus fermentation), Kwak et al. (1996) suggested a two stage
brevis g,h,p,r Lactobacillus fructivorans k
Lactobacillus fermentation process starting with a non-lactose ferment-
plantarum o,p Lactobacillus hilgardii k
Lactobacillus ing yeast such as Saccharomyces cerevisiae.
helveticus a,b,h Lactobacillus fermentum r
Lactobacillus The properties of yeasts found in kefir grains vary. For
acidophilus g,p,r Lactobacillus viridescens r example, some of the yeasts found in kefir grains are cap-
Lactobacillus
able of fermenting lactose, while some are not. Also, it
Lactococci
has been observed that some types of yeasts are located at
Lactococcus lactis subsp. lactis a,c,e,f,g,h,k,o,r
the surface of the grain, while others inhabit the interior.
Lactococcus lactis subsp. cremoris a,e,f
It may be that yeasts located at different locations in the
Streptococci kefir grains play different roles in the fermentation pro-
Streptococcus thermophilus e,h cess. (Iwasawa et al. 1982; Wyder et al. 1997). Iwasawa
et al. (1982) showed that the electrophoretic pattern of the
Enterococci
yeast Torulopsis holmii isolated from Danish kefir grains
**
Enterococcus durans d ,e
demonstrated patterns indicating the presence of ten differ-
(reported as Streptobacterium durans in ref. d; reported as
Streptococcus durans in ref. e) ent enzymes. Wyder et al. (1997) used restriction analysis
of the two ITS regions to show that yeasts from five kefir
Leuconostocs
grain samples of different origins had unique patterns,
Leuconostoc sp. r
indicating the presence of different yeast species in kefir
*
Leuconostoc mesenteroides a,b,g ,o
grains from different origins. Like kefir bacteria, the pro-
(reported as Leuconostoc kefir in ref. g)
file of yeasts is different in kefir grains when compared to
Acetic acid bacteria
the final kefir product (Wyder et al. 1997). Abraham and
Acetobacter sp. o De Antoni (1999) showed that the yeast population in
*
Acetobacter pasteurianus g kefir produced from cows’ milk using grains was two logs
(reported as Acetobacter rancens in ref. g)
higher than when the same grains were added to soy milk.
Acetobacter aceti a,d
Other bacteria
7. Other uses of kefir grains
Bacillus sp. r Micrococcus sp. r
Bacillus subtilis g Escherichia coli r The ability of kefir grains to grow in milk whey prompted
Rimada and Abraham (2001) to study whether kefir grains
a b c d
Koreleva 1991; Lin et al. 1999; Pintado et al. 1996; Rosi 1978; ref.
could be added to whey produced as a by-product of the
e f g
¨
Yuksekdag et al. 2004; Dousset and Caillet 1993; Ottogalli et al. 1973;
dairy industry in Argentina, thereby producing a value-
h j k
Simova et al. 2002; Kandler and Kunath 1983; Yoshida and Toyoshima
l n o
1994; Fujisawa et al. 1988; Takizawa et al. 1994; Garrote et al. 2001; added product called kefiran. Kefiran was produced at a
p r
Santos et al. 2003; Angulo et al. 1993.
rate of 103 mg/l following fermentation at 438C for 120 h,
with an inoculation rate of 100 g grains per litre of milk.
Athanasiadis et al. (1999) showed that kefir yeast cells
and haemagglutination properties. In addition, these
that had been immobilized on de-lignified cellulose were
two bacteria were also shown to adhere to Caco-2 cells,
capable of producing commercially important quantities of
raising the possibility that these bacteria would be good
ethanol from glucose over a wide variety of temperatures
probiotics.
(5–308C). Production of volatiles (e.g. ethanal, ethyl acet-
ate, propanol-1, isobutyl alcohol and amyl alcohols) was
found to depend on fermentation temperature. Ethyl acet-
6.2 Yeasts
ate content did not change as fermentation temperature
It has been recognized that yeasts play an important role decreased, although contents of total volatiles during fer-
in the preparation of fermented dairy products, where they mentations at 58C were 38% of those carried out at 308C.
can provide essential growth nutrients such as amino acids Using this system, it was shown that glucose produced the
and vitamins, alter the pH, secrete ethanol and produce fastest fermentation compared to fructose or sucrose,
CO2 (Viljoen 2001). The yeasts in kefir have been less although glucose-based fermentations also yielded lower
well studied than kefir bacteria, although it is obvious that concentrations of amyl alcohols, ethyl acetate and ethanol
Kefir – a complex probiotic E.R. Farnworth
6
Table 4. Yeasts found in kefir grains and kefir Table 5. Definitions of functional foods and probiotics
* *
Kluyveromyces marxianus a,b,f ,g,h,i,j,k,m ,n Candida friedrichii n Functional foods
(reported as Saccharomyces lactis in A functional food is one that is consumed as part of a usual diet,
ref. f; reported as Kluyveromyces lactis and is demonstrated to have physiological benefits and/or reduce
in ref. m) the risk of chronic disease beyond basic nutritional functions.
Saccharomyces sp. k Candida (Health Canada 2004)
pseudotropicalis f
Probiotics
*
Saccharomyces cerevisiae a,d,e,f ,g,j,m,n Candida tenuis f
Live microorganisms that, when administered in adequate
(reported as Saccharomyces carlbergensis
amounts, confer a health benefit on the host. (FAO/WHO 2002).
in ref. f)
Report of a Joint FAO/WHO Working Group, ‘Guidelines for
Saccharomyces unisporus c,h,j,m Candida the Evaluation of Probiotics in Food’, London, Ontario, Canada,
inconspicua g 2002.
*
Saccharomyces exiguus l Candida maris g
(reported as Torolopsis holmii in ref. l)
Saccharomyces turicensis h Candida lambica j (1982b) who reported decreases in biotin, vitamin B12 and
Saccharomyces delbrueckii d Candida pyridoxine, and significant increases in folic acid, as com-
tannotelerans e pared to non-fermented milk.
Saccharomyces dairensis n Candida valida 6 e
Torulaspora delbrueckii a,h,m Candida kefyr a,j,n
9. Bioactive ingredients in kefir
Brettanomyces anomalus h Candida holmii j,m
Issatchenkia occidentalis j Pichia The area of functional foods (see Table 5 for definition)
fermentans b,m,n has attracted a great deal of interest since it is now recog-
nized that many foods contain bioactive ingredients which
a b c d e
Koreleva 1991; Lin et al. 1999; Pintado et al. 1996; Rosi 1978; Dous-
g h
offer health benefits or disease resistance. A subset of
set and Caillet 1993; ref. fOttogalli et al. 1973; Simova et al. 2002; Wyder
i j
and Puhan 1997, 1999; Yoshida and Toyoshima 1994; Engel et al. 1986; functional foods is probiotic foods, from which there are
k m n
Garrote et al. 2001; ref. lIwasawa et al. 1982; Angulo et al. 1993; Rohm
several possible sources of bioactive ingredients. The
et al. 1992
microorganisms themselves (dead or alive), metabolites of
the microorganisms formed during fermentation (including
(Athanasiadis et al. 2001). The de-lignified cellulose mate-
antibiotics or bactericides), or breakdown products of the
rial supporting kefir yeast cells were able to ferment a
food matrix, such as peptides, may be responsible for
mixture of whey and raisins to produce a fermented pro-
these beneficial effects (Ouwehand and Salminen 1998;
duct with an alcohol content of 4.4% v/v.
Farnworth 2002; see Figure 3). Kefir has a long tradition
of offering health benefits, especially in eastern Europe
8. Composition of kefir ´
(Halle et al. 1994). There are several compounds in kefir
that may have bioactive properties.
The composition of kefir depends greatly on the type of
milk that was fermented (Kneifel and Mayer 1991). How-
ever, during the fermentation, changes in composition of
9.1 Exopolysaccharides
nutrients and other ingredients have also been shown to
occur. (Bottazzi et al. 1994). L(þ) lactic acid is the Exopolysaccharides of differing structures and composi-
tions are produced by a variety of lactic acid bacteria
organic acid in highest concentrations after fermentation
including Lactobacillus, Streptococcus, Lactococcus and
and is derived from approximately 25% of the original
Leuconostoc (De Vuyst and Degeest 1999; Ruas-Madiedo
lactose in the starter milk (Alm 1982d; Dousset and Cail-
et al. 2002.). These cell-surface carbohydrates confer pro-
let 1993). The amino acids valine, leucine, lysine and ser-
tective and adaptive properties on their bacterial produ-
ine are formed during fermentation, while the quantities of
cers; since they are often loosely bound to the cell mem-
alanine and aspartic acid increase when compared to raw
milk (Alm 1982e). Bottazzi et al. (1994) reported the brane, they are, therefore, easily lost to their environment
(Jolly et al. 2002). In food products, exopolysaccharides
occurrence of acetic acid in their kefir, although others
¨ often contribute to organoleptic and stability characteris-
reported that no acetic acid was present (Guzel-Seydim
et al. 2000a, 2000b). tics. A unique polysaccharide called kefiran has been
found in kefir grains; grains may also contain other exopo-
Kneifel and Mayer (1991) found that appreciable
lysaccharides.
amounts of pyridoxine, vitamin B12, folic acid and biotin
Kefiran contains D-glucose and D-galactose only in a
were synthesized during kefir production, depending on
ratio of 1:1. Hydrolysis reactions followed by NMR ana-
the source of kefir grains used, while thiamine and ribofla-
lyses have been used to determine the chemical structure
vin levels were reduced. These results contrast with Alm
Kefir – a complex probiotic E.R. Farnworth 7
exopolysaccharides in different media (Grobben et al.
Probiotic
1995; Van Geel-Schutten et al. 1999). Furthermore, Santos
(Kefir) et al. (2003) recently reported that they have also isolated
an exopolysaccharide closely related to kefiran.
Kefiran dissolves slowly in cold water and quickly in
hot water, and forms a viscous solution at 2% concentra-
Fermentation Bacteria, Yeasts Metabolites
´
tion (La Riviere et al. 1967). Carboxymethyl kefiran has a
Products
viscosity that is 14 times that of kefiran, although this is
still much lower than those of other thickening agents
used in the food industry, thus limiting any practical uses
of kefiran or carboxymethyl kefiran (Mukai et al. 1990).
Intestinal Microbial Digestion, Metabolism,
Kefiran can form weak gels when added to k-carrageenan
Population Immune Status,
Disease Resistance (1% 1:4 kefiran/k-carrageenan), which have gelation tem-
peratures and melting temperatures similar to those of
Figure 3. Probiotic effects on metabolism and health.
guar/k-carrageenan gels (Pintado et al. 1996).
Since its initial isolation, it has been reported that
kefiran may be produced by a variety of bacteria isolated
of kefiran (see Figure 4). The proposed structure is a
from kefir grains which have been obtained from several
branched hexa- or heptasaccharide repeating unit that is
´
sources (La Riviere and Kooiman 1967; Toba et al. 1987;
itself composed of a regular pentasaccharide unit to which
Mukai et al. 1990; Hosono et al. 1990; Yokoi et al. 1991;
one or two sugar residues are randomly linked (Kooiman
Pintado et al. 1996; Mitsue et al. 1999; Micheli et al.
1968; Micheli et al. 1999). Subsequent methylation/hydro-
1999; Santos et al. 2003). Whether in fact the bacteria
lysis studies have shown that the structure of kefiran may
reported are the same has not been studied, nor has any
be more complex than first thought (Mukai et al. 1988;
definitive identification been published to fully character-
Mukai et al. 1990). Methylation and NMR analyses have
ize those bacteria reported as kefiran producers.
also been used to verify the production of kefiran by new
Bacteria which produce exopolysaccharides are often
bacterial strains (Yokoi et al. 1991). A closer examination
found in milk or milk products, although studies have
of chemical data published by Mukai et al. (1990) raises
shown that maximum production of exopolysaccharide
the question if, in fact, two exopolysaccharides are being
may occur in chemically defined media (containing a
produced that have very similar chemical structure and
´ carbohydrate source, mineral salts, amino acids/peptides,
properties. La Riviere et al. (1967) reported that their
vitamins and nucleic acids) at a constant pH (Mozzi
kefiran had a 1:1 glucose to galactose ratio and an optical
rotation of þ68.08, while Mukai et al. (1990) isolated a et al. 1996; Dupont et al. 2000). The potential health
properties of kefiran have prompted several groups to
kefiran with a glucose to galactose ratio of 0.9:1.1 and an
optical rotation of þ548. Examples can be found in the lit- develop media and growing conditions that optimize
kefiran production (Toba et al. 1987; Yokoi et al. 1990;
erature where the same bacterial strain produced different
→ 6)-β-D-Gp-{1→2(6)}-β-D-Galp-(1→4)-α-D-Galp-(1→3)-β -D-Galp-(1→4)-β-D-Gp-(1
6(2)

21
1
β-D-Gp
Figure 4. Proposed chemical structure of kefiran. Reprinted from Carbohydrate Research 7, Kooiman, P. The chemical
structure of kefiran, the water-soluble polysaccharide of the kefir grain, pp 200–211. Copyright 1968 with permission
from Elsevier.
8
Delta O.D. /cfu/ml(x10-12)
8
IM
Lc. lactis
7
6
5
4
3
2
1
0
10
1
IM
10
5
IM
00
2
IM
00
5
IM
00
8
IM
01
1
IM
02
2
IM
02
3
IM
01
4
IM
01
5
IM
08
2
Kefir – a complex probiotic E.R. Farnworth
Lb. kefirgranum
Lb. helveticus
Lb. kefir
Ln. mesenteroides
Lc. cremoris (Prt-)
Kefir Strains Reference Strains
Figure 5. Proteinase activity of bacteria from kefir and kefir grains.
9.2 Bioactive peptides
Yokoi and Watanabe 1992; Micheli et al. 1999; Mitsue
et al. 1999). Media based on lactic acid whey have been
Many organisms possess enzymes (e.g. proteinases and
found to be optimum for kefiran production. A batch
peptidases) that are able to hydrolyse the protein in a med-
procedure using a modified MRS media (MRSL) was
ium, thereby supporting growth of the organism by liberat-
reported by Micheli et al. 1999 to produce consistent
ing peptides and amino acids (Thomas and Pritchard
yields of 2 g/l of kefiran. The best kefiran yields, how-
1987; Matar et al. 1996). The action of proteinase and
ever, have been reported by Mitsue et al. (1999) when
peptidase enzymes on milk proteins can theoretically
they combined the kefiran producing bacterium, Lactoba-
result in a very large number of possible peptides. An ana-
cillus kefiranofaciens, with the yeast Torulaspora del-
lysis of the proteinase activity of kefir grain bacterial iso-
brueckii. When these two organisms were grown in a 50
lates has shown that several isolates have high proteinase
l fermentor in a fed-batch protocol, a yield of 3740 mg/l
activities (see Figure 5), which increases the possibility
was obtained over a 7 day period.
that bioactive peptides may be present in kefir. In their
No measurements have been reported with regard to
˘
¨
study of lactic acid bacteria in Turkish kefir, Yuksekdag
kefiran concentration in the final kefir product. However,
et al. (2004b) showed that 13 out of 21 lactococci strains
a comparison of the carbohydrate content of milk
had measurable proteolytic activity.
(USDA 2004) and that of kefir shows a more than dou-
Initial studies on the peptide content of kefir drink have
bling of the carbohydrate content; how much of this is
shown that kefir contains a large number of peptides and
kefiran is not known. Abraham and De Antoni (1999)
that the majority of kefir peptides have molecular weights
did show that the polysaccharide content of kefir from
of 5000 kDa (Farnworth 2005, unpublished results).
cows’ milk was almost twice that of kefir produced
from soy milk.
Kefir grains grown in soy milk produce an exopolysac-
10. Health benefits of kefir
charide that Liu et al. (2002) have shown to be primarily
composed of D-glucose and D-galactose (ratio 1.00: 0.43), Kefir has had a long history of being beneficial to health
with a molecular weight of approximately 1.7 Â 106 Da. in Eastern European countries, where it is associated with
Kefir – a complex probiotic E.R. Farnworth 9
general wellbeing. It is easily digested (Alm 1982c) and is the polysaccharide stimulated PP cells, causing them to
often the first weaning food received by babies. Many of secrete water-soluble factors that, in turn, enhanced the
the studies regarding health benefits of kefir have been mitogenic response of thymocytes and splenocytes in nor-
published in Russian and Eastern European journals and mal mice.
therefore are not easily accessible to Western science
(Batinkov 1971; Ormisson and Soo 1976; Evenshtein
10.2 Inhibition of tumour growth
1978; Safonova et al. 1979; Ivanova et al. 1981; Sukhov
et al. 1986; Besednova et al. 1997; Oleinichenko et al. Shiomi et al. (1982) were the first to report the antitumour
effects of a water-soluble polysaccharide (approximate
1999). However, the health benefits of kefir were demon-
molecular weight 1 000 000 Da) isolated from kefir grains.
strated in Canada as early as 1932 (Rosell 1932).
Whether given orally or intraperitoneally, the polysacchar-
ide was able to inhibit the growth of Ehrlich carcinoma or
10.1 Stimulation of the immune system
Sarcoma 180 compared to control mice receiving no kefir-
derived polysaccharide (Shiomi et al. 1982; Murofushi
It has been proposed that stimulation of the immune sys-
et al. 1983). The mechanism of action was not clear, since
tem may be one mechanism whereby probiotic bacteria
in vitro incubation of the two cancer cell lines with the
may exert many of their beneficial effects (De Simone
et al. 1991; Gill 1998); this may be a direct effect of the polysaccharide showed low cytotoxicity during 42 hours of
bacteria themselves (Cross 2002). However, peptides incubation. This group then went on to show that this
formed during the fermentation process or during diges- water-soluble polysaccharide was able to reach the spleen
tion have also been shown to be bioactive, and demon- and thymus of mice and, based on the response to thymus-
strate a variety of physiological activities, including stimu- dependent and thymus-independent antigens, concluded
lation of the immune system in animal models (LeBlanc that oral immune enhancement was mediated through T-
et al. 2002; Matar et al. 2003). cell, but not B-cell activity. (Murofushi et al. 1986). More
Thoreux and Schmucker (2001) fed kefir produced from recently, a water soluble polysaccharide fraction from kefir
grains to young (6 months) and old (26 months) rats and grains was shown to inhibit pulmonary metastasis of Lewis
found an enhanced mucosal immune response in the lung carcinoma, whether the kefir-derived polysaccharide
young animals, as shown by a higher anti-cholera toxin was given orally before or after tumour transplantation.
Murofushi et al. (1983) also reported the antitumour effec-
(CT) IgA response compared to controls. Both young and
old rats had significantly increased total non-specific IgG tiveness of kefir grain polysaccharides regardless of the
blood levels, and a decreased systemic IgG response to time of administration, although they cautioned that larger
CT. Taken together, Thoreux and Schmucker concluded doses may only be more effective if administered after
that kefir, like other probiotics, was exerting an adjuvant establishment of the tumours. A water-insoluble fraction
effect on the mucosal immune system, perhaps produced containing kefir grain microorganisms, rather than the
by bacterial cell wall components. water-soluble polysaccharide fraction, significantly inhib-
Stimulation of the immune system may also occur due ited metastasis of highly colonized B16 melanoma. (Furu-
kawa et al. 1993; Furukawa et al. 2000). It was suggested
to the action of exopolysaccharides found in kefir grains.
Murofushi et al. (1983, 1986) used the method of La Riv- that the water-soluble polysaccharide suppressed tumour
´
iere et al. (1967) for the extraction of kefiran from kefir growth by means of the lymphokine activated macrophage
grains to produce a water-soluble polysaccharide fraction (Mf) via the gut-associated lymphoid tissue, while the
that they fed to mice. The reduction in tumour growth that water-insoluble microorganism fraction acted through an
they observed was linked to a cell-mediated response, and increase of NK cell activity.
it appeared that the total dose of the polysaccharide deter- Feeding kefir itself (2 g/kg body weight by intubation)
mined its effectiveness. Furukawa et al. (1992) have also was more effective in inhibiting tumour (Lewis lung carci-
shown that a water-soluble fraction of kefir grains may act noma) growth than yoghurt, when given for 9 days after
tumour inoculation (Furukawa et al. 1990). It was also
as a modulator of the immune response.
The effect of kefir exopolysaccharides on the immune shown that mice receiving kefir had an improved delayed-
system may be dependent on whether the host is healthy type hypersensitivity response compared to tumour-bearing
or has developed any tumours. Furukawa et al. (1996) mice receiving no kefir, although the mean survival time
was not affected (Furukawa et al. 1991). Kubo et al.
incubated kefir grain polysaccharides with Peyer’s Patch
(PP) cells from tumour-bearing mice and found that the (1992) also reported that feeding kefir (100–500 mg/kg
supernatant of this mixture enhanced proliferation of sple- body weight) inhibited the proliferation of Ehrlich ascites
nocytes from normal mice and increased the mitogenic carcinoma. In addition, kefir, from which the grains had
activities of lipopolysaccharides (LPS) and phytohaemag- been removed by filtration, were shown to kill or arrest
glutinin-P (PHA-P) in splenocytes. They concluded that the growth of fusiform cell sarcomas induced by 7,12-
Kefir – a complex probiotic E.R. Farnworth
10
10.3 Kefir and lactose intolerance
dimethylbenzanthracene in mice when the kefir was
injected intraperitoneally (Cevikbas et al. 1994). Examina-
A proportion of the global population is unable to digest
tion of tissue in kefir-treated mice showed a small amount
lactose (the major sugar found in milk), because of insuffi-
of mitosis, some stromal connections and, in some cases,
cient intestinal b-galactosidase (or lactase) activity (Alm
disappearance of tumour necrosis.
1982a). Research has shown, however, that lactose maldi-
Hosono et al. (1990) showed that isolates of Streptococ-
gestors are able to tolerate yoghurt, providing the number
cus, Lactobacillus and Leuconostoc in Mongolian kefir all
of live bacteria present in the yoghurt consumed is high
showed strong in vitro binding to amino acid pyrolysates
enough (Pelletier et al. 2001). It is believed that the bac-
which are believed to be mutagens and are commonly
teria in the yoghurt matrix are protected by the buffering
found in food. Similarly, Miyamoto et al. (1991) reported
effect of the yoghurt. Bacterial cells remain viable, and
that three slime-producing strains of Streptococcus lactis
the bacterial cell walls remain intact, and thus the b-galac-
subsp. cremoris found in German kefir had strong desmu-
tosidase enzyme contained in the yoghurt-producing bac-
tagenic properties, which they attributed to the ability of
teria (L. acidophilus) is protected during transit through
such strains to bind to a known mutagen. Using an Ames
the stomach until it arrives at the upper gastrointestinal
test, Yoon et al. (1999) showed that Lactobacillus spp.
tract (Montes et al. 1995; De Vrese et al. 2001). It has
isolated from kefir and yoghurt had antimutagenic proper-
also been shown that fermented milk products have a
ties against the mutagen 2-nitrofluorene.
slower transit time than milk, which may further improve
Liu et al. (2002) studied the effects of soy milk and
lactose digestion (Vesa et al. 1996; Labayen et al. 2001).
cows’ milk fermented with kefir grains on the growth of
Some kefir grains have been shown to possess b-galac-
tumours in mice, using freeze-dried kefir (produced from
tosidase activity which remains active when consumed
either soy or cows’ milk) from which the grains had been
(De Vrese et al. 1992). A recent study has shown that a
removed following fermentation. Mice were injected with
commercial kefir produced using a starter culture contain-
0.2 Â 108 Sarcoma 180 cells one week prior to the start
ing six bacteria (but not L. acidophilus) and one yeast was
of the feeding portion of the experiment. Tumour growth
equally as effective as yoghurt in reducing breath hydro-
(volume) was estimated for up to 30 days, after which
gen in adult lactose maldigestors (Hertzler and Clancy
tumours were removed and weighed. Both soy milk kefir
2003). Severity of flatulence in this group was also
(À70.9%) and cows’ milk kefir (À64.8%) significantly
reduced when either yoghurt or kefir was consumed com-
inhibited tumour growth, compared to mice in the positive
pared to milk.
control group. Microscopic examination of the tumours
De Vrese et al. (1992) showed that when pigs were fed
indicated that apoptosis may have been responsible for
kefir containing fresh grains, their plasma galactose con-
reduced tumour growth. Similar effects of yoghurt on
centrations rose significantly higher than pigs given kefir
apoptosis have been reported (Rachid et al. 2002). Mice
containing heated grains. The diet containing kefir and
fed unfermented soy milk did not have reduced tumour
fresh grains had a b-galactosidase activity of 4.4 U/l, which
volumes at day 30, and Liu et al. (2002) concluded that
was identified as being responsible for the hydrolysis of
either the microorganisms themselves or any polysacchar-
lactose in the intestine, thus yielding galactose that can be
ides formed during fermentation by the kefir grains micro-
absorbed. Kefir itself contains no galactose (Alm 1982).
flora were responsible for the antitumour response. Genis-
tein itself has been shown to inhibit tumours (Murrill
et al. 1996; Constantinou et al. 1996), although in this
10.4 Antimicrobial properties of kefir
study genistein levels did not change during the fermenta-
There are data to show that many lactobacilli are capable
tion process. Mice consuming kefir samples also had sig-
nificantly increased levels of IgA in their small intestines of producing a wide range of antimicrobial compounds,
compared to control animals, and it was proposed that the including organic acids (lactic and acetic acids), carbon
dioxide, hydrogen peroxide, ethanol, diacetyl and peptides
PP tissue was increasing IgA secretion into the intestine in
(bacteriocins) that may be beneficial not only in the reduc-
response to food antigens.
¨
Guven et al. (2003) proposed an alternative suggestion tion of foodborne pathogens and spoilage bacteria during
as to how kefir may protect tissues. They showed that food production and storage, but also in the treatment and
prevention of gastrointestinal disorders and vaginal infec-
mice exposed to carbon tetrachloride (a hepatotoxin to
tions (Tahara and Kanatani 1997; Zamfir et al. 1999;
induce oxidative damage) and given kefir by gavage had
´
decreased levels of liver and kidney malondialdehyde, Bonade et al. 2001; Messens and De Vuyst 2002; Jamuna
indicating that kefir was acting as an antioxidant. Further- and Jeevaratnam 2004).
Garrote et al. (2000) tested the inhibitory activity of a
more, their data showed that kefir was more effective than
supernatant of cows’ milk fermented with kefir grains,
vitamin E (which is well known to have antioxidative
properties) in protecting against oxidative damage. against Gram-negative and Gram-positive bacteria. Gram-
Kefir – a complex probiotic E.R. Farnworth 11
10.5 Behaviour of kefir bacteria in the
positive microorganisms were inhibited to a greater extent
than Gram-negative microorganisms; moreover, both lactic gastrointestinal tract
and acetic acids were found in the supernatants. Garrote
One of the criteria for probiotic bacteria is that they
et al. (2000) showed that milk supplemented with lactic
should be able to withstand the harsh conditions of the
acid or lactic acid plus acetic acid at the concentrations
gastrointestinal tract, including extreme pH conditions pre-
found in the kefir supernatant also had inhibitory activity
sent in the stomach and the action of bile salts and diges-
against E. coli 3. They concluded that organic acids pro-
tive enzymes (Lee and Salminen 1995). It is also believed
duced during kefir fermentation could have important bac-
that one way in which probiotic bacteria could protect
teriostatic properties even in the early stages of milk fer-
against pathogenic bacteria would be to compete with or
mentation. Cevikbas et al. (1994) found similar results
displace pathogenic bacteria by adhering to intestinal
against Gram-positive coccus, staphylococcus, and Gram-
epithelial cells. (Kirjavainen et al. 1998; Fujiwara et al.
positive bacillus, and noted that kefir grains were more
2001; Gibson and Rastall 2003).
effective with regard to their antibacterial properties than
No results from human feeding trials have been pub-
the final kefir product.
lished with regard to the ability of the microorganisms
Kefir grains themselves have inhibitory power against
found in kefir to traverse the upper GI tract in large num-
bacteria that can be preserved during lyophilization, parti-
bers and arrive at the large intestine. Kefir, because it is
cularly when glycerol is added as a cryopreservative
milk based, is able to buffer the pH of the stomach when
(Brialy et al. 1995). Fresh kefir grains were found to inhi-
ingested and thereby provide time for many of the bacteria
bit the growth of the bacteria Streptococcus aureus, Kleb-
to pass through to the upper small intestine (Farnworth
siella pneumoniae and Escherichia coli, but not the yeasts
et al. 2003). Santos et al. (2003) isolated 58 strains of
Candida albicans and Saccharomyces cerevisiae. Leuco-
Lactobacillus spp. and isolates of L. paracasei, L. plan-
nostoc mesenteroides and Lactobacillus plantarum, iso-
tarum, L. delbrueckii, L. acidophilus and L. kefiranofa-
lated from kefir grains, have both been shown to produce
ciens from different sources of kefir grains and exposed
antimicrobial compounds that are present in kefir. Both
them to an MRS medium at pH 2.5 and MRS containing
inhibit Gram-positive and Gram-negative bacteria, have a
0.3% Oxgall (bile salts). They found that all strains sur-
molecular weight of approximately 1000 kDa and are heat
vived 4 h incubation at pH 2.5, but did not grow. Eighty-
stable, although their antimicrobial properties are reduced
five percent of isolates showed high resistance to Oxgall,
after exposure to proteolytic enzymes (Serot et al. 1990).
but had delayed growth.
Santos et al. (2003) showed that lactobacilli isolated from
The caco-2 cell assay has been used to show that many
kefir grains had antimicrobial activities against E. coli (43/
of the lactobacilli isolated from kefir grains are able to
58 strains), Listeria monocytogenes (28/58 strains), Salmo-
bind to enterocyte-like cells (Santos et al. 2003), although
nella typhimurium (10/58 strains), S. enteritidis (22/58
the authors also cautioned that results using this model
strains), S. flexneri (36/58 strains) and Yersinia enterocoli-
might not necessarily apply in vivo.
tica (47/58 strains). Bacteriocins were thought to be
Human studies of the effects of diet on intestinal micro-
responsible, although they were not identified.
flora are limited to the analysis of faecal samples,
In a study in which foodborne bacterial pathogens (E.
although no detailed human study has been published in
coli O157:H7, L. monocytogenes 4b, Y. enterocolitica 03)
which kefir has been used. Marquina et al. (2002) used
were added at the beginning of yoghurt or kefir fermenta-
mice to study the effect of consuming kefir (source not
tion, both kefir and yoghurt failed to inhibit pathogenic
defined) in a feeding study that lasted 7 months. They
bacterial growth. For kefir, this was explained as being
were able to show that the numbers of lactic acid bacteria
due to the slow acid development during fermentation.
in the mouse small and large intestines increased signifi-
Interestingly, fermentations of kefir and yoghurt combina-
cantly. Streptococci increased by 1 log, while sulfite-redu-
tions proved to be more effective at pathogen suppression
cing clostridia decreased by 2 logs.
than single fermentation (Gulmez and Guven 2003)
Hydrogen peroxide is another metabolite produced by
˘
¨
some bacteria as an antimicrobial compound. Yuksekdag
et al. (2004a) showed that all 21 isolates of lactic acid
10.6 Kefir and cholesterol metabolism
bacteria from Turkish kefir produced hydrogen peroxide
Positive effects of yoghurt consumption on cholesterol
(0.04–0.19 ug/ml). In a later paper, they reported that 11
out of 21 strains of kefir lactococci produced hydrogen metabolism have been reported (Kiessling et al. 2002;
˘
¨
peroxide (Yuksekdag et al. 2004b). All lactococci strains Xiao et al. 2003), although a review of the literature
were effective in inhibiting growth of Streptococcus aur- reveals that the results are at best moderate, and are often
inconsistent (Taylor and Williams 1998; St-Onge et al.
eus, but were less effective against E. coli NRLL B-704
and Pseudomonas aeruginosa. 2000; Pereira and Gibson 2002).
Kefir – a complex probiotic E.R. Farnworth
12
Several hypotheses have been proposed regarding the found in kefir. Furthermore, there is evidence to show that
possible mechanism of action employed by bacteria to kefir consumption not only affects digestion, but also
reduce cholesterol levels (St. Onge et al. 2002). Vujicic influences metabolism and immune function in humans.
et al. (1992) showed that kefir grains from Yugoslavia,
Hungary and the Caucase region were able to assimilate 12. References
cholesterol in milk either incubated at 208C for 24 h
Abraham, A.G. and De Antoni, G.L. 1999. Characterization of
(reductions of up to 62%) or incubated and stored at 108C kefir grains grown in cows’ milk and in soya milk. Journal of
for 48 h (reductions of up to 84%). These authors claimed Dairy Research 66: 327-333.
that their results indicated that kefir grains had a choles- Alm, L. 1982a. Effect of fermentation on lactose, glucose, and
galactose content in milk and suitability of fermented milk
terol-degrading enzyme system. Similar results were
products for lactose intolerant individuals. Journal of Dairy
reported for 27 lactic acid bacterial strains. However, it
Science 65: 346-352.
was pointed out that isolates from dairy products had Alm, L. 1982b. Effect of fermentation on B-vitamin content of
lower cholesterol-assimilating capacity than strains iso- milk in Sweden. Journal of Dairy Science 65: 353-359.
lated from infant faeces (Xanthopoulos et al. 1998). Alm, L. 1982c. Effects of fermentation on curd size and digest-
ibility of milk proteins in vitro of Swedish fermented milk
In a clinical trial in which 13 subjects were fed 500 ml/
products. Journal of Dairy Science 65: 509-514.
day of kefir for 4 weeks in a placebo-controlled design, per-
Alm, L. 1982d. Effect of fermentation on L(þ) and D(À) lactic
centage changes in serum triglycerides compared to base- acid in milk. Journal of Dairy Science 65: 515-520.
line levels were lower (although not significantly) than Alm, L. 1982e. Effect of fermentation on proteins of Swedish
when subjects consumed unfermented milk; the percentage fermented milk products. Journal of Dairy Science 65: 1696-
1704.
serum high-density lipoprotein (HDL) cholesterol change
Angulo, L., Lopez, E. and Lema, C. 1993. Microflora present in
compared to baseline increased (although not significantly)
kefir grains of the Galician region (North-West of Spain).
when subjects consumed kefir compared to milk (St. Onge Journal of Dairy Research 60: 263-267.
et al. 2002). Similarly, Kiessling et al. (2002) found that Arihara, K., Toba, T. and Adachi, S. 1990. Immunofluorescence
HDL levels increased after 6 months of feeding yoghurt microscopic studies on distribution of Lactobacillus kefiranofa-
ciens and Lactobacillus kefir in kefir grains. International
supplemented with Lactobacillus acidophilus and Bifido-
Journal of Food Microbiology 11: 127-134.
bacterium longum, thereby producing an improved low-
Athanasiadis, I., Boskou, D., Kanellaki, M. and Koutinas, A.A.
density lipoprotein (LDL)/HDL cholesterol ratio. 1999. Low-temperature alcoholic fermentation by delignified
cellulosic material supported cells for kefir yeast. Journal of
Agricultural and Food Chemistry 47: 4474-4477.
11. Conclusions Athanasiadis, I., Boskou, D., Kanellaki, M. and Koutinas, A.A.
2001. Effect of carbohydrate substrate on fermentation by kefir
Many probiotic products have been formulated that con-
yeast supported on delignified cellulosic materials. Journal of
tain small numbers of different bacteria. The microbiologi- Agricultural and Food Chemistry 49: 658-663.
cal and chemical composition of kefir indicates that it is a Athanasiadis, I., Paraskevopoulou, A., Blekas, G. and Kiosseo-
much more complex probiotic, as the large number of dif- glou, V. 2004. Development of a novel beverage by fermenta-
tion with kefir granules. Effect of various treatments. Biotech-
ferent bacteria and yeast found in it distinguishes it from
nology Progress 20: 1091-1095.
other probiotic products. Since the yeasts and bacteria pre-
Batinkov, E.L. 1971. Use of milk and kefir in peptic ulcer of the
sent in kefir grains have undergone a long association, the stomach and duodenum. Voprosy Pitani 30:(4) 89-91.
resultant microbial population exhibits many similar char- Besednova, N.N., Epshtein, L.M., Gazha, A.K., Borovskaia,
acteristics, making isolation and identification of indivi- G.A., Besednov, A.L., Rozhzhov, I.V. and Smolina, T.P. 1997.
Therapeutic-prophylactic milk products with a new immuno-
dual species difficult. Many of these microorganisms are
corrector of natural origin. Voprosy Pitani 3: 31-34.
only now being identified by using advanced molecular
Beshkova, D.M., Simova, E.D., Simov, Z.I., Frengova, G.I. and
biological techniques. The study of kefir is made more dif- Spasov, Z.N. 2002. Pure cultures for making kefir. Food
ficult, because it appears that many different sources of Microbiology 19: 537-544.
kefir grains exist that are being used to produce kefir. Beshkova, D.M., Simova, E.D., Frengova, G.I., Simov, Z.I. and
Dimitrov, Z.P. 2003. Production of volatile aroma compounds
The production of kefir depends on the synergistic inter-
by kefir starter cultures. International Dairy Journal 13:
action of the microflora in kefir grains. During the fermen-
529-535.
tation process, the yeasts and bacteria in kefir grains pro- ´
Bonade, A., Murelli, F., Vescovo, M. and Scolari, G. 2001. Par-
duce a variety of ingredients that give kefir its unique tial characterization of a bacteriocin produced by Lactobacillus
taste and texture. After fermentation, the finished kefir helveticus. Letters in Applied Microbiology 33: 153-158.
Bottazzi, V. and Bianchi, F. 1980. A note on scanning electron
product contains many ingredients that are proving to be
microscopy of micro-organisms associated with the kefir gran-
bioactive. At least one exopolysaccharide has been identi-
ule. Journal of Applied Bacteriology 48: 265-268.
fied in kefir, although others may be present. Many bac- Bottazzi, V., Zacconi, C., Sarra, P.G., Dallavalle, P. and Parisi,
teria found in kefir have been shown to have proteinase M.G. 1994. Kefir microbiologia, chimica, e tecnologia.
activity, and a large number of bioactive peptides has been L’industria Latte 30: 41-62.
Kefir – a complex probiotic E.R. Farnworth 13
Farnworth, E.R. 2002. Unique problems in designing and testing
Brialy, C., Rivalland, P., Coiffard, L. and de Roeck Holtzhauer,
probiotic foods. Food Science Central. Available at: http://
Y. 1995. Microbiological study of lyophilized dairy kefir.
Folia Microbiology 40: 198-200. www.foodsciencecentral.com/library.html#ifis/3803
Farnworth, E.R., editor. 2003. Handbook of fermented functional
Cevikbas, A., Yemni, E., Ezzedenn, F.W., Yardimici, T., Cevik-
foods. CRC Press, Boca Raton, USA.
bas, U. and Stohs, S.J. 1994. Antitumoural antibacterial and
antifungal activities of kefir and kefir grain. Phytotherapy Farnworth, E.R. 2004. The beneficial health effects of fermented
Research 8: 78-82. foods – potential probiotics around the world. Journal of
Nutraceuticals, Functional and Medical Foods (in press).
Clementi, F., Gobbetti, M. and Rossi, J. 1989. Carbon dioxide
synthesis by immobilized yeast cells in kefir production. Farnworth, E.R., Mainville, I. and Arcand, Y. 2003. Buffering
Milchwissenschaft 44: 70-74. capacity of milk products in an in vitro upper gastrointestinal
Constantinou, A.I., Mehta, R.G. and Vaughan, A. 1996. Inhibition tract model. Canadian Federation of Biological Societies, 46
Annual Meeting, Ottawa, June 12-14. Abstract # F065A.
of N-methyl-N-nitrosourea-induced mammary tumors in rats by
the soybean isoflavones. Anticancer Research 16: 2617-2620. Fujisawa, T., Adachi, S., Toba, T., Arihara, K. and Mitsuoka, T.,
Cross, M.L. 2002. Microbes versus microbes: Immune signals 1988. Lactobacillus kefiranofaciens sp. nov. isolated from kefir
grains. International Journal of Systematic Bacteriology 38: 12-
generated by probiotic lactobacilli and their role in protection
against microbial pathogens. FEMS Immunology and Medical 14.
Microbiology 34: 245-253. Fujiwara, S., Seto, Y., Kimura, A. and Hashiba, H. 2001. Intest-
inal transit of orally administered streptomycin-rifampican-
De Simone, C., Rosati, E., Moretti, S., Bianchi, S.B., Vesely, R.
resistant variant of Bifidobacterium longum SBT2928: its long-
and Jirillo, E. 1991. Probiotics and stimulation of the immune
response. European Journal of Clinical Nutrition 45: (2, term survival and effect on the intestinal microflora and meta-
Suppl.) 32-34. bolism. Journal of Applied Microbiology 90: 43-52.
Furukawa, N., Matsuoka, A. and Yamanaka, Y. 1990. Effects of
De Vrese, M., Keller, B. and Barth, C.A. 1992. Enhancement of
intestinal hydrolysis of lactose by microbial b-galactosidase orally administered yoghurt and kefir on tumor growth in
(EC 3.2.1.23) of kefir. British Journal of Nutrition 67: 67-75. mice. Journal of the Japanese Society of Nutrition and Food
Science 43: 450-453.
De Vrese, M., Stegelmann, A., Richter, B., Fenselau, S., Laue,
C. and Schrezenmeir, J. 2001. Probiotics-compensation for lac- Furukawa, N., Matsuoka, A., Takahashi, T. and Yamanaka, Y.
tase insufficiency. American Journal of Clinical Nutrition 1991. Effects of fermented milk on the delayed-type hypersen-
73:(2, Suppl.) 421S-429S. sitivity response and survival day in mice bearing Meth-A.
Animal Science Technology (Japan) 62: 579-585.
De Vuyst, L. and Degeest, B. 1999. Heteropolysaccharides
from lactic acid bacteria. FEMS Microbiology Reviews 23: Furukawa, N., Iiyama, R., Takahashi, T. and Yamanaka, Y.
153-177. 1992. Effect of oral administration of water soluble fraction
from kefir grain on antibody production in mice. Animal
Dmitrovskaya, G.P. et al. 1986. USSR Patent SU 1227 146 A
Science Technology (Japan) 63: 428-436.
(quoted in Mann 1989).
Furukawa, N., Yokokawa, Y., Takahashi, T. and Yamanaka, Y.
Dousset, X. and Caillet, F. 1993. Aspects microbiologiques et
biochimiques de la fermentation du kefir. Microbiologie Ali- 1993. Effects of oral administration of water soluble fraction
ments Nutrition 11: 463-470. from kefir grains on glucose consumption and phagocytosis of
peritoneal exudate cells in mice. Animal Science and Technol-
Duitschaever, C.L., Kemp, N. and Emmons, D. 1987. Pure cul-
ogy (Japan) 64: 60-67.
ture formulation and procedure for the production of kefir.
Milchwissenschaft 42: 80-82. Furukawa, N., Takahashi, T. and Yamanaka, Y. 1996. Effects of
supernatant of Peyer’s Patch cell culture with kefir grain com-
Duitschaever, C.L., Kemp, N. and Emmons, D. 1988a. Com-
parative evaluation of five procedures for making kefir. Milch- ponents on the mitogenic response of thymocyte and spleno-
cyte in mice. Animal Science Technology (Japan) 67: 153-159.
wissenschaft 43: 343-345.
Furukawa, N., Matsuoka, A., Takahashi, T. and Yamanaka, Y.
Duitschaever, C.L., Kemp, N. and Smith, A.K. 1988b. Micro-
2000. Anti-metastatic effect of kefir grain components on Lewis
scopic studies of the microflora of kefir grains and of kefir
made by different methods. Milchwissenschaft 43: 479-481. lung carcinoma and highly metastatic B16 melanoma in mice.
Journal of Agriculture Science Tokyo Nogyo Daigaku 45: 62-70.
Duitschaever, C.L., Toop, D.H. and Buteau, C. 1991. Consumer
acceptance of sweetened and flavoured kefir. Milchwis- Garrote, G.L., Abraham, A.G. and De Antoni, G.L. 1997. Preser-
vation of kefir grains, a comparative study. Lebensmittel-Wis-
senschaft 46: 227-229.
senschaft und-Technologie 30: 77-84.
Dupont, I., Roy, D. and Lapointe, G. 2000. Comparison of exo-
polysaccharide production by strains of Lactobacillus rhamno- Garrote, G.L., Abraham, A.G. and De Antoni, G.L. 1998. Char-
sus and Lactobacillus paracasei grown in chemically defined acteristics of kefir prepared with different grain: milk ratios.
Journal of Dairy Research 65: 149-154.
medium and milk. Journal of Industrial Microbiology and Bio-
technology 24: 251-255. Garrote, G.L., Abraham, A.G. and De Antoni, G.L. 2000. Inhibi-
tory power of kefir: the role of organic acids. Journal of Food
Engel, V.G., Krusch, U. and Teuber, M. 1986. Mikrobiologische
zusammensetzung von kefir. I Helfen. Milchwissenschaft 41: Protection 63: 364-369.
418-421. Garrote, G.L., Abraham, A.G. and De Antoni, G.L. 2001. Chemi-
cal and microbiological characterisation of kefir grains. Jour-
Evenshtein, E.M. 1978. Use of kefir for stimulation of gastric
nal of Dairy Research 68: 639-652.
secretion and acid-formation in patients with pulmonary tuber-
culosis. Problemy Tuberkuleza 2: 82-84. Garrote, G.L., Delfederico, L., Bibiloni, R., Abraham, A.G.,
FAO/WHO. 2001. CODEX Standard for Fermented Milks #243. Perez, P.F., Semorile, L. and De Antoni, G.L. 2004. Lactoba-
Available at http://www.codexalimentarius.net/web/standard_ cilli isolated from kefir grains: evidence of the presence of S-
layer proteins. Journal of Dairy Research 71: 222-230.
list.jsp
Farnworth, E.R. 1999. Kefir: from folklore to regulatory Gawel, J. and Gromadka, M. 1978. Changements chimiques au
´
approval. Journal of Nutraceuticals, Functional and Medical cours de la fermentation et de la maturation du kefir. XX Inter-
Foods 1: 57-68. national Dairy Congress Brief Communication Vol E: 850.
Kefir – a complex probiotic E.R. Farnworth
14
Kiessling, G., Schneider, J. and Jahreis, G. 2002. Long-term con-
Gibson, G.R. and Rastall, R.A. 2003. Gastrointestinal infections
and the protective role of probiotics and prebiotics. Food sumption of fermented dairy products over 6 months increases
HDL cholesterol. European Journal of Clinical Nutrition 56:
Science and Technology Bulletin: Functional Foods. Available
843-849.
at http://www.foodsciencecentral.com/fsc/ixid3664.
Kirjavainen, P.V., Ouwehand, A.C., Isolauri, E. and Salminen,
Gill, H.S. 1988. Stimulation of the immune system by lactic cul-
tures. International Dairy Journal 8: 535-544. S.J. 1998. The ability of probiotic bacteria to bind to human
intestinal mucus. FEMS Microbiology Letters 167: 185-189.
Gobbetti, M., Rossi, J. and Toba, T. 1990. Batch production of
Klupsch, H.J. 1984. Method of producing kefir. German Federal
kefir. Analysis of the relationships among the biological com-
ponents of the system. Brief Communications and Abstracts of Republic Patent Application DE 33 00 122 A1
the XXIII International Dairy Congress, Montreal, Abstract # (DE3300122A1).
Kneifel, W. and Mayer, H.K. 1991. Vitamin profiles of kefirs
P740 391.
made from milks of different species. International Journal of
Grobben, H.J., Sikkema, J., Smith, M.R. and Bont, J.A.M. 1995.
Food Science Technology 26: 423-428.
Production of extracellular polysaccharides by Lactobacillus del-
Kojima, S., Takizawa, S., Tamura, S., Fujinaga, S., Benno, Y.
brueckii spp. bulgaricus NCFB 2772 grown in a chemically
defined medium. Journal of Applied Bacteriology 79: 103-107. and Nakase, T. 1993. An improved medium for the isolation
¨ ¨ of Lactobacilli from kefir grains. Bioscience Biotechnology
Gulmez, M. and Guven, A. 2003. Survival of Escherichia coli
and Biochemistry 57: 199-120.
0157:H7, Listeria monocytogenes 4b and Yersinia enterocoli-
tica 03 in different yoghurt and kefir combinations as prefer- Kooiman, P. 1968. The chemical structure of kefiran, the water-
mentation contaminant. Journal of Applied Microbiology 95: soluble polysaccharide of the kefir grain. Carbohydrate
Research 7: 200-211.
631-636.
¨ ¨ ¨
Guven, A., Guven, A. and Gulmez, M. 2003. The effect of kefir Koroleva, N.S. 1982. Special products (kefir, koumyss, etc.). Pro-
on the activities of GSH-Px, GST, CAT, GSH and LPO levels ceedings XXI International Dairy Congress, Moscow 2: 146-151.
in carbon tetrachloride-induced mice tissues. Journal of Veter- Koroleva, N.S. 1988a. Technology of kefir and kumys. Bulletin
inary Medicine B 50: 412-416. of the International Dairy Federation 227: 96-100.
¨
Guzel-Seydim, Z.B., Seydim, A.C., Greene, A.K. and Bodine, Koroleva, N.S. 1988b. Starters for fermented milks, section 4:
A.B. 2000a. Determination of organic acids and volatile flavor kefir and kumys starters. Bulletin of the International Dairy
substances in kefir during fermentation. Journal of Food Com- Federation 227: 3540.
position and Analysis 13: 35-43. Koroleva, N.S. 1991. Products prepared with lactic acid bacteria
¨
Guzel-Seydim, Z.B., Seydim, A.C. and Greene, A.K. 2000b. and yeasts. In: Robinson, R.K., editor. Therapeutic properties
Organic acids and volatile flavor components evolved during refri- of fermented milks: 159-179. Elsevier Applied Sciences Pub-
gerated storage of kefir. Journal of Dairy Science 83: 275-277. lishers, London, UK.
´ ´
Halle, C., Leroi, F., Dousset, X. and Pidoux, M. 1994. Les kefirs. Koroleva, N.S. and Bavina, N.A. 1970. Influences des conditions
´
Des associations bacteries lactique-levures, In: de Roissart, H. de cultures des grains de kefhir sur la microflore et les caracter-
´ries lactiques: aspects fonda-
and Luquet, F.M., editors. Bacte istiques biochimiques du levain de kefir. Proceedings XVIII
mentaux et technologiques Vol 2: 169-182. Uriage, France. Congress International de Laiterie, Sydney Vol 1F: 424-.
Hertzler, S.R. and Clancy, S.M. 2003. Kefir improves lactose Koroleva, N.S., Rozhkova, I.V. and Bavina, N.A. 1978. Basic
digestion and tolerance in adults with lactose maldigestion. factors affecting the microflora and quality of kefir. Proceed-
Journal of the American Dietetic Association 103: 582-587. ings XX International Dairy Congress, Paris: 843.
Hosono, A., Tanabe, T. and Otani, H. 1990. Binding properties Kosikowski, F.V. and Mistry, V.V. 1997. Cheese and
of lactic acid bacteria isolated from kefir milk with mutagenic fermented milk foods. F.V. Kosikowski LLC, Wesport, Connecti-
amino acid pyrolyzates. Milchwissenschaft 45: 647-651. cut, USA.
Ismail, A.A., El-Nockrashy, S.A. and Khorshid, M.A. 1983. A Kubo, M., Odani, T., Nakamura, S., Tokumaru, S. and Matsuda,
beverage from separated buffalo milk fermented with kefir H. 1992. Pharmacological study on kefir - a fermented milk
grains. International Journal of Dairy Technology 36: 117-118. product in Caucasus. I. On antitumor activity (1). Yakugaku
Zasshi 112: 489-495 (in Japanese - abstract only).
Ivanova, L.N., Bulatskaya, A.N. and Silaev, A.E. 1981. Industrial pro-
duction of kefir for children. Molochna i Apromyshlemast: 15-16 Kuo, C-Y. and Lin, C-W. 1999. Taiwanese kefir grains: their
(DSA no. 106). growth, microbial and chemical composition of fermented
milk. Australian Journal of Dairy Technology 54: 19-23.
Iwasawa, S., Ueda, M., Miyata, N., Hirota, T. and Ahiko, K.
1982. Identification and fermentation character of kefir yeast. Kwak, H.S., Park, S.K. and Kim, D.S. 1996. Biostabilization of
Agricultural and Biological Chemistry 46: 2631-2636. kefir with a nonlactose-fermenting yeast. Journal of Dairy
Science 79: 937-942.
Jamuna, M. and Jeevaratnam, K. 2004. Isolation and characteri-
zation of lactobacilli from some traditional fermented foods Labayen, I., Forga, L., Gonzalez, A., Lenoir-Wijnkoop, I. and
and evaluation of the bacteriocin. Journal of General and Martinez, J.A. 2001. Relationship between lactose digestion,
Applied Microbiology 50: 79-90. gastrointestinal transit time and symptoms in lactose malabsor-
bers after dairy consumption. Alimentary Pharmacology and
Jolly, L., Vincent, S.J.F., Duboc, P. and Neeser, J-R. 2002.
Exploiting exopolysaccharides from lactic acid bacteria. Anto- Therapeutics 15: 543-549.
´
nie van Leeuwenhoek 82: 367-374. La Riviere, J.W.M., Kooiman, P. and Schmidt, K. 1967. Kefiran,
a novel polysaccharide produced in the kefir grain by Lactoba-
Kabore, P. 1992. Method for preparing kefir-type stabilized fer-
mented beverages. French Patent Application FR 2 665 826 cillus brevis. Archiv fur Mikrobiologie 59: 269-278.
´ ´
A1 (FR2665826A1). LeBlanc, J.G., Matar, C., Valdez, J.C., LeBlanc, J. and Perdigon,
Kandler, O. and Kunath, P. 1983. Lactobacillus kefir sp. nov., a G. 2002. Immunomodulating effects of peptidic fractions
issued from milks fermented with Lactobacillus helveticus.
component of the microflora of kefir. Systematic and Applied
Journal of Dairy Science 85: 2733-2742.
Microbiology 4: 286-294.
Lee, Y-K. and Salminen, S. 1995. The coming of age of probio-
Kemp, N. 1984. Kefir, the champagne of cultured dairy products.
tics. Trends in Food Science and Technology 6: 241-245.
Cultured Dairy Products Journal XX: 29-30.
Kefir – a complex probiotic E.R. Farnworth 15
Mozzi, F., de Giori, G.S., Oliver, G. and de Valdez, G. 1996.
Libudzisz, Z. and Piatkiewicz, A. 1990. Kefir production in
Exopolysaccharide production by Lactobacillus casei under
Poland. Dairy Industry International 55: 31-33.
controlled pH. Biotechnology Letters 18: 435-439.
Lin, C-W., Chen, H-L. and Liu, J-R. 1999. Identification and
Muir, D.D., Tamime, A.Y. and Wszolek, M. 1999. Comparison
characterisation of lactic acid bacteria and yeasts isolated from
of the sensory profiles of kefir, buttermilk and yoghurt. Inter-
kefir grains in Taiwan. Australian Journal of Dairy Technol-
national Journal of Dairy Technology 52: 129-134.
ogy 54: 14-18.
Mukai, T., Toba, T., Itoh, T. and Adachi, S. 1988. Structural
Linossier, J.P. and Dousset, X. 1994. Stimulation de la crois-
´ microheterogeneity of kefiran from kefir grains. Japanese
sance et du metabolisme de Lactobacillus kefir par Candida
Journal of Zootechnology 59: 167-176.
kefir. Microbiologie Aliments Nutrition 12: 341-351.
Mukai, T., Toba, T., Itoh, T., Nimura, T. and Adachi, S. 1990.
Liu, J-R. and Lin, C-W. 2000. Production of kefir from soymilk
with or without added glucose, lactose or sucrose. Journal of Carboxylmethyl kefiran: preparation and viscometric proper-
ties. Journal of Food Science 55: 1483-1484.
Food Science 65: 716-719.
Murofushi, M., Shiomi, M. and Aibara, K. 1983. Effect of orally
Liu, J-R., Chen, M-J. and Lin, C-W. 2002. Characterization of
polysaccharide and volatile compounds produced by kefir grains administered polysaccharide from kefir grain on delayed-type
hypersensitivity and tumor growth in mice. Japanese Journal
grown in soymilk. Journal of Food Science 67: 104-108.
of Medical Science and Biology 36: 49-53.
Liu, J-R., Wang, S-Y., Lin, Y-Y. and Lin, C-W. 2002. Antitumor
activity of milk kefir and soy milk kefir in tumor-bearing Murofushi, M., Mizuguchi, J., Aibara, K. and Matuhasi, T. 1986.
mice. Nutrition and Cancer 44: 182-187. Immunopotentiative effect of polysaccharide from kefir grain,
KGF-C, administered orally in mice. Immunopharmacology
Mann, E.J. 1985. Kefir and koumiss. Dairy Industry International
12: 29-35.
50: 11-12.
Mann, E.J. 1989. Kefir. Dairy Industries International XX: 39-41, 47. Murrill, W.B., Brown, N.M., Zhang, J.X., Manzolillo, P.A.,
Barnes, S. and Lamartiniere, C.A. 1996. Prepubertal genistein
Margulis, L. 1995. From kefir to death. In: Brockman, J. and
exposure suppresses mammary cancer and enhances gland dif-
Matson, K., editors. How things are: 69-78. William Morrow
ferentiation in rats. Carcinogenesis 17: 1451-1457.
and Co., New York, USA.
Neve, H. 1992. Analysis of kefir grain starter cultures by
Marquina, D., Santos, A., Corpas, I., Munoz, J., Zazo, J. and Pie-
scanning electron microscopy. Milchwissenschaft 47: 275-278.
nado, J.M. 2002. Dietary influence of kefir on microbial activ-
ities in the mouse bowel. Letters in Applied Microbiology 35: Oleinichenko, E.V., Mitrokhin, S.D., Nonikov, V.E. and Minaev,
V.I. 1999. Effectiveness of acipole in prevention of enteric
136-140.
dysbacteriosis due to antibacterial therapy. Anitibiotiki i Khi-
Marshall, V., Cole, W.M. and Brooker, B.E. 1984. Observations
mioterapia 44: 23-25(in Russian - abstract only).
on the structure of kefir grains and the distribution of the
microflora. Journal of Applied Bacteriology 57: 491-497. Ormisson, A.A. and Soo, T.R. 1976. Effect of lactic acid milk
and kefir on the indicators of acid-base equilibrium of arterial
Matar, C., Amiot, J., Savoie, L. and Goulet, J. 1996. The effect
blood in healthy young children and patients with acute pneu-
of milk fermentation by Lactobacillus helveticus on the release
monia and acute bronchitis. Pediatrica 10: 37-38(translated
of peptides during in vitro digestion. Journal of Dairy Science
from Russian).
79: 971-979.
´ Ottogalli, G., Galli, A., Resmini, P. and Volonterio, G. 1973.
Matar, C., LeBlanc, J.G., Martin, L. and Perdigon, G. 2003.
Composizione microbiologia, chimica ed ultrastruttura dei
Biologically active peptides released in fermented milk:
ganuli di kefir. Annali di Microbiolgia 23: 109-121.
role and functions. In Farnworth, E.R., editor. Handbook of
fermented functional foods: 177-201. CRC Press, Boca Raton, Ouwehand, A.C. and Salminen, S.J. 1998. The health effects of
USA. cultured milk products with viable and non-viable bacteria.
International Dairy Journal 8: 749-758.
Messens, W. and De Vuyst, L. 2002. Inhibitory substances pro-
duced by Lactobacilli isolated from sourdoughs-a review. Pelletier, X., Laure-Boussuge, S. and Donazzolo, Y. 2001.
International Journal of Food Microbiology 72: 31-43. Hydrogen excretion upon ingestion of dairy products in lac-
tose-intolerant male subjects: importance of the live flora. Eur-
Micheli, L., Uccelletti, D., Palleschi, C. and Crescenzi, V. 1999.
opean Journal of Clinical Nutrition 55: 509-512.
Isolation and characterisation of a ropy Lactobacillus strain
producing the exopolysaccharide kefiran. Applied Microbiology Petersson, H.E., Christiansson, A. and Ekelund, K. 1985. Making
and Biotechnology 53: 69-74. kefir without grains. Scandinavian Journal of Dairy Technol-
ogy and Know How 2: 58-60.
Mitsue, T., Tachibana, K. and Fujio, Y. 1999. Efficient kefiran
production by a mixed culture of Lactobacillus kefiranofaciens Pereira, D.I. and Gibson, G.R. 2002. Effects of consumption of
KF-75 and yeast strains. Seibutsu-kogaku 77: 99-103. probiotics and prebiotics on serum lipid levels in humans. Cri-
tical Reviews in Biochemistry and Molecular Biology 37: 259-
Miyamoto, T., Morita, H., Nishioka, K., Kataoka, K., Izumimoto,
281.
M. and Kuyama, T. 1991. Constituent species of lactic acid
bacteria from kefir and their desmutagenic properties. Japa- Pintado, M.E., Lopes Da Silva, J.A., Fernandes, P.B., Malcata,
nese Journal of Dairy and Food Science 40: 111-112. F.X. and Hogg, T.A. 1996. Microbiological and rheological
studies on Portuguese kefir grains. International Journal of
Molska, I., Kocon, J. and Zmarlicki, S. 1980. Electron micro-
Food Science and Technology 31: 15-26.
scopic studies on structure and microflora of kefir grains. Acta
´
Alimentaria Polonica 6: 145-154. Rachid, M.M., Gobbato, N.M., Valdez, J.C., Vitalone, H.H. and
´
Perdigon, G. 2002. Effect of yoghurt on the inhibition of an
Molska, I., Nowosielska, R. and Frelik, I. 2003. Changes in
intestinal carcinoma by increasing cellular apoptosis. Interna-
microbiological quality of kefir and yoghurt on the Warsaw
tional Journal of Immunopathology and Pharmacology 15:
market in the years 1995-200. Roczniki Paanstwowego Zak-
tadu Higieny 54: 145-152 (in Polish, abstract only). 209-216.
Rea, M.C., Lennartsson, T., Dillon, P., Drinan, F.D., Reville,
Montes, R.G., Bayless, T.M., Saavedra, J.M. and Perman, J.A.
1995. Effect of milks inoculated with Lactobacillus acidophi- W.J., Heapes, M. and Cogan, T.M. 1996. Irish kefir-like
lus or a yoghurt starter culture in lactose-maldigesting chil- grains: their structure, microbial composition and fermentation
kinetics. Journal of Applied Bacteriology 81: 83-94.
dren. Journal of Dairy Science 78: 1657-1664.
Kefir – a complex probiotic E.R. Farnworth
16
Taylor, G.R. and Williams, C.M. 1998. Effects of probiotics and
Rimada, P.S. and Abraham, A.G. 2001. Polysaccharide produc-
prebiotics on blood lipids. British Journal of Nutrition 80:
tion by kefir grains during whey fermentation. Journal of
Dairy Research 68: 653-661. S225-30.
Thomas, T.D. and Pritchard, G.G. 1987. Proteolytic enzymes
Rosell, J.M. 1932. Yoghurt and kefir in their relation to health and
of dairy starter cultures. FEMS Microbiology Reviews 46: 245-
therapeutics. Canadian Medical Association Journal: 341-345.
268.
Rosi, J. and Rossi, J. 1978a. I Microrganismi del kefir: I fermenti
lattici. Scieza e Tecnica Lattiero-Casearia 29: 291-305. Thompson, J.K., Johnston, D.E., Murphy, R.J. and Collins, M.A.
1990. Characteristics of a milk fermentation from rural North-
Rosi, J. 1978b. I Microrganismi del kefir: gli acetobatteri. Scieza
ern Ireland which resembles kefir. Irish Journal of Food
e Tecnica Lattiero-Casearia 29: 221-227.
Science Technology 14: 35-49.
Rosi, J. 1978c. I Microrganismi del kefir: I Lieviti. Scieza e Tec-
Thoreux, K. and Schmucker, D.L. 2001. Kefir milk enhances
nica Lattiero-Casearia 29: 59-67.
intestinal immunity in young but not old rats. Journal of Nutri-
Rosi, J. and Gobbetti, M. 1991. Impiego di un multistarter per la
tion 131: 807-812.
produzione in continuo di kefir. Annals of Microbiology 41:
Toba, T., Abe, S., Arihara, K. and Adachi, S. 1986. A medium
223-226.
for the isolation of capsular bacteria from kefir grains. Agricul-
Ruas-Madiedo, P., Hugenholtz, J. and Zoon. 2002. An overview
tural and Biological Chemistry 50: 2673-2674.
of the functionality of exopolysaccharides produced by lactic
Toba, T., Abe, S. and Adachi, S. 1987. Modification of KPL
acid bacteria. International Dairy Journal 12: 163-171.
medium for polysaccharide production by Lactobacillus sp.
Safonova, T.Y., Yatsyk, G.V., Yurkov, Y.A. and Volkova, L.D.
isolated from kefir grain. Japanese Journal of Zootechnology
1979. Effect of varying types of feeding on fatty acid compo-
Science 58: 987-990.
sition of blood serum in premature infants. Voprosy Pitani 6:
Toba, T., Arihara, K. and Adachi, S. 1990. Distribution of micro-
44-49(in Russian, abstract only).
organisms with particular reference to encapsulated bacteria in
Santos, A., San Mauro, M., Sanchez, A., Torres, J.M. and Mar-
kefir grains. International Journal of Food Microbiology 10:
quina, D. 2003. The antimicrobial properties of different
219-224.
strains of Lactobacillus spp. isolated from kefir. Systematic
Toba, T., Uemura, H., Mukai, T., Fujii, T., Itoh, T. and Adachi,
and Applied Microbiology 26: 434-437.
S. 1991. A new fermented milk using capsular polysaccharide-
Serot, T., Dousset, X., Zucca, J. and Torcatis, N. 1990. Mise en
´ producing Lactobacillus kefiranofaciens isolated from kefir
evidence et purification partielle de substances antibacteriennes
grains. Journal of Dairy Research 58: 497-502.
produites par Leuconostoc mesenteroides et Lactobacillus
´ Tokumaru, S. 1987. United States Patent US 4702923.
plantarum isoles de grains de kefyr. Microbiologie Aliments
Nutrition 8: 71-76. USDA. 2004. Nutrient Data Laboratory. Available at http://
www.codexalimentarius.net/web/standard_list.jsp.
Serova, E. V. 1997. Trade and market policy in Russia’s agricul-
Van Geel-Schutten, G.H., Faber, E.J., Smit, E., Bonting, K., Smith,
ture: 1992-1996. Available at http://www.iet.ru/personal/agro/
M.R., Ten Brink, B., Kamerling, J.P., Vliegenthart, J.F. and
berlin.htm.
Dijkhuizen, L. 1999. Biochemical and structural characterization
Shiomi, M., Sasaki, K., Murofushi, M. and Aibara, K. 1982.
of the glucan and fructan exopolysaccharides synthesized by the
Antitumor activity in mice of orally administered polysacchar-
Lactobacillus reuteri wild-type strain and by mutant strains.
ide from kefir grain. Japanese Journal of Medical Science and
Applied Environmental Microbiology 65: 3008-3014.
Biology 35: 75-80.
Vesa, T.H., Marteau, P., Zidi, S., Briet, F., Pochart, P. and Ram-
Simova, E., Beshkova, D., Angelov, A., Hristozova, Ts., Fren-
baud, J.C. 1996. Digestion and tolerance of lactose from
gova, G. and Spasov, Z. 2002. Lactic acid bacteria and yeasts
yoghurt and different semi-solid fermented dairy products con-
in kefir grains and kefir made from them. Journal of Industrial
taining Lactobacillus acidophilus and bifidobacteria in lactose
Microbiology and Biotechnology 28: 1-6.
maldigesters-is bacterial lactase important? European Journal
St-Onge, M.-P., Farnworth, E.R. and Jones, P.J.H. 2000. Fermen-
of Clinical Nutrition 50: 730-733.
ted and non-fermented dairy product consumption: effects on
Viljoen, B.C. 2001. The ineraction between yeasts and bacteria
cholesterol levels and metabolism. American Journal of Clini-
in dairy environments. International Journal of Food Micro-
cal Nutrition 71: 674-681.
biology 69: 37-44.
St-Onge, M.-P., Farnworth, E.R., Savard, T., Chabot, D., Mafu,
¨
Vujicic, I.F., Vulic, M. and Konyves, T, 1992. Assimilation of
A. and Jones, P.J.H. 2002. Kefir consumption does not alter
cholesterol in milk by kefir cultures. Biotechnology Letters 14:
plasma lipid levels or cholesterol fractional synthesis rates
relative to milk in hyperlipidemic men. BMC Complementary 847-850.
and Alternative Medicine. Available at http://www.biomedcen- Wyder, M.-T. and Puhan, Z. 1997. A rapid method for identifica-
tion of yeasts from kefyr at species level. Milchwissenschaft
tral.com/1472-6882/2/1/
52: 327-330.
Sukhov, S.V., Kalamkarova, L.I., Ll’chenko, L.A. and Zhangaby-
Wyder, M.-T., Spillmann, H., Meile, L. and Puhan, Z. 1997.
lov, A.K. 1986. Microfloral changes in the small and large
Investigation of the yeast flora in dairy products: a case study
intestines of chronic enteritis patients on diet therapy including
of kefyr. Food Technology and Biotechnology 35: 299-304.
sour milk products. Voprosy Pitani 4: 14-17 (in Russian,
abstract only). Wyder, M.-T., Tzanetakis, N., Meile, L. and Teuber, M. 1999.
Description of Saccharomyces turicensis sp. nov., a new spe-
Tahara, T. and Kanatani, K. 1997. Isolation and partial amino acid
cies from kefyr. Systematic and Applied Microbiology 22: 420-
sequence of bacteriocins produced by Lactobacillus acidophilus.
Bioscience, Biotechnology and Biochemistry 61: 884-886. 425.
Xanthopoulos, V., Tzanetakis, N. and Litopoulou-Tzanetaki, E.
Takizawa, S., Kojima, S., Tamura, S., Fujinaga, S., Benno, Y. and
Nakase, T. 1994. Lactobacillus kefirgranum sp. nov. and Lacto- 1988. In vitro effect of Lactobacilli and Pediococci on choles-
terol. Microbiologie Aliments Nutrition 16: 199-203.
bacillus parakefir sp. nov., two new species from kefir grains.
International Journal of Systematic Bacteriology 44: 435-439. Xiao, J.Z., Kondo, S., Takahashi, N., Miyaji, K., Oshida, K., Hir-
amatsu, A., Iwatsuki, K., Kokubo, S. and Hosono, A. 2003.
Tamime, A.Y., Muir, D.D. and Wszolek, M. 1999. Kefir, kou-
miss and kishk. Dairy Industries International 64: 32-33. Effects of milk products fermented by Bifidobacterium longum
Kefir – a complex probiotic E.R. Farnworth 17
yeast from kefir. Journal of the Japanese Society of Nutrition
on blood lipids in rats and healthy adult male volunteers. Jour-
and Food Science 47: 55-59.
nal of Dairy Science 86: 2452-2461.
Yokoi, H., Watanabe, T., Fujii, Y., Toba, T. and Adachi, S. ˘
¨
Yuksekgag, Z.N., Beyath, Y. and Aslim, B. 2004a. Metabolic
1990. Isolation and characterization of polysaccharide-produ- activities of Lactobacillus spp. strains isolated from kefir. Nah-
cing bacteria from kefir grains. Journal of Dairy Science 73: rung/Food 48: 218-220.
1684-1689. ˘
¨
Yuksekgag, Z.N., Beyatli, Y. and Aslim, B. 2004b. Deter-
Yokoi, H., Watanabe, T., Fujii, Y., Mukai, T., Toba, T. and mination of some characteristics coccoid forms of lactic
Adachi, S. 1991. Some taxonomical characteristics of encapsu- acid bacteria isolated from Turkish kefirs with natural
lated Lactobacillus sp. KPB-167B isolated from kefir grains probiotic. Lebensmittel-Wissenschaft und-Technologie 37:
and characterization of its extracellular polysaccharide. Inter- 663-667.
national Journal of Food Microbiology 13: 257-264.
Zamfir, M., Callewaert, R., Cornea, P.C., Savu, L., Vatafu, I.
Yokoi, H. and Watanabe, T. 1992. Optimum culture conditions
and De Vuyst, L. 1999. Purification and characterization of a
for production of kefiran by Lactobacillus sp. KPB-167B iso-
bacteriocin produced by Lactobacillus acidophilus IBB 801.
lated from kefir grains. Journal of Fermentation and Bioengi-
Journal of Applied Microbiology 87: 923-931.
neering 74: 327-329.
Zimovetz, V.N. and Boyko, R.L. 2000. Ukraine. Available at
Yoon, Y.H., Cho, J.K., Baek, Y.J. and Huh, C.S. 1999. Anti-
http://www.minagro.kiev.ua/english/Analitic/Milk/index-e.html.
mutagenic activity of Lactobacillus spp. isolated from kefir
and yoghurt and non-starter strains. Korean Journal of Animal Zourari, A. and Anifantakis, E.M. 1988. Le kir. Caractes phy-
sico-chimiques,microbiologiques et nutritionnels. Technologie
Science (in Korean, abstract only) 41: 39-44.
de production. Une revue. Le Lait 68: 373-392.
Yoshida, T. and Toyoshima, K. 1994. Lactic acid bacteria and